HK1248114A1 - 通過人成肌細胞移植的疾病預防和緩解 - Google Patents

通過人成肌細胞移植的疾病預防和緩解

Info

Publication number
HK1248114A1
HK1248114A1 HK18107641.8A HK18107641A HK1248114A1 HK 1248114 A1 HK1248114 A1 HK 1248114A1 HK 18107641 A HK18107641 A HK 18107641A HK 1248114 A1 HK1248114 A1 HK 1248114A1
Authority
HK
Hong Kong
Prior art keywords
cure
disease prevention
myoblast transplantation
human myoblast
human
Prior art date
Application number
HK18107641.8A
Other languages
English (en)
Inventor
K Law Peter
Original Assignee
K Law Peter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by K Law Peter filed Critical K Law Peter
Publication of HK1248114A1 publication Critical patent/HK1248114A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2878Muscular dystrophy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/324Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
HK18107641.8A 2013-08-16 2018-06-13 通過人成肌細胞移植的疾病預防和緩解 HK1248114A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/968,982 US20150050300A1 (en) 2013-08-16 2013-08-16 Disease prevention and alleviation by human myoblast transplantation

Publications (1)

Publication Number Publication Date
HK1248114A1 true HK1248114A1 (zh) 2018-10-12

Family

ID=49303813

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18107641.8A HK1248114A1 (zh) 2013-08-16 2018-06-13 通過人成肌細胞移植的疾病預防和緩解

Country Status (7)

Country Link
US (2) US20150050300A1 (zh)
EP (1) EP2837683B1 (zh)
JP (1) JP2015051969A (zh)
CN (3) CN108042571A (zh)
AU (1) AU2013231029B2 (zh)
ES (1) ES2615553T3 (zh)
HK (1) HK1248114A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018055433A1 (en) 2016-09-21 2018-03-29 Peter Law Autonomously controllable pull wire injection catheter, robotic system comprising said catheter and method for operating the same
GB2567377A (en) * 2016-10-27 2019-04-10 Law Peter Compositions comprising myoblasts for tumor growth inhibition and prevention of cancer cell metastasis by implantation
AU2018375315A1 (en) * 2017-11-28 2020-06-04 The Board Of Trustees Of The University Of Illinois Multi-chimeric cell and therapy for transplantation and treatment of immune deficiencies and genetic disorders
CN113559125A (zh) * 2020-04-26 2021-10-29 苏州大学 一种治疗糖尿病的干细胞药物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130141A (en) * 1988-05-24 1992-07-14 Law Peter K Compositions for and methods of treating muscle degeneration and weakness
US5139481A (en) * 1991-08-07 1992-08-18 The General Hospital Corporation Treatment for type II diabetes
CN1127343C (zh) 1994-12-13 2003-11-12 彼得·K·罗 治疗哺乳动物疾病的成肌细胞组合物
CA2225185A1 (en) 1997-08-11 1999-02-11 Peter K. Law Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
WO2002028470A1 (en) * 2000-09-12 2002-04-11 Law Peter K Myogenic cell transfer catheter and method
WO2003085092A2 (en) 2002-04-01 2003-10-16 Law Peter K Cellular transplantation for heart regeneration
CN1688701A (zh) * 2002-08-09 2005-10-26 彼得·K·罗 成肌细胞转移治疗心力衰竭的机理
CA2496434A1 (en) * 2002-08-23 2004-03-04 Peter K. Law Biologic skin repair and enhancement
WO2004030706A2 (en) 2002-10-01 2004-04-15 Law Peter K Bioactive implants
WO2005020916A2 (en) 2003-08-29 2005-03-10 Law Peter K Myoblast treatment of diseased or weakened organs

Also Published As

Publication number Publication date
US10449219B2 (en) 2019-10-22
CN103550784A (zh) 2014-02-05
CN107648267A (zh) 2018-02-02
JP2015051969A (ja) 2015-03-19
AU2013231029A1 (en) 2015-03-05
EP2837683A1 (en) 2015-02-18
ES2615553T3 (es) 2017-06-07
CN108042571A (zh) 2018-05-18
AU2013231029B2 (en) 2016-10-13
US20180000867A1 (en) 2018-01-04
US20150050300A1 (en) 2015-02-19
EP2837683B1 (en) 2016-11-16

Similar Documents

Publication Publication Date Title
IL286759A (en) Therapeutic methods and preparations
GB201302447D0 (en) Therapeutic and diagnostic target
HK1248114A1 (zh) 通過人成肌細胞移植的疾病預防和緩解
HK1219962A1 (zh) 人抗白細胞介素- 抗體
GB201313704D0 (en) Engineered neural tissue
GB201303308D0 (en) Therapeutic and diagnostic target
GB201319255D0 (en) Therapeutic compositions and methods
GB201410990D0 (en) General cure to diseases
GB201316908D0 (en) Therapeutic and diagnostic target
GB201314515D0 (en) Therapeutic and diagnostic target
GB201314502D0 (en) Therapeutic and diagnostic target
GB201313865D0 (en) Therapeutic and diagnostic target
GB201311899D0 (en) Therapeutic and diagnostic target
GB201308759D0 (en) Therapeutic and diagnostic target
GB201308013D0 (en) Therapeutic and diagnostic target
GB201304740D0 (en) Therapeutic and diagnostic target
GB201304402D0 (en) Therapeutic and diagnostic target
GB201304406D0 (en) Therapeutic and diagnostic target
GB201303648D0 (en) Therapeutic and diagnostic target
GB201303573D0 (en) Therapeutic and diagnostic target
GB201303529D0 (en) Therapeutic and diagnostic target
GB201303532D0 (en) Therapeutic and diagnostic target
GB201303571D0 (en) Therapeutic and diagnostic target
GB201303535D0 (en) Therapeutic and diagnostic target
GB201303486D0 (en) Therapeutic and diagnostic target